Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

Código QR

Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

Abstract Chronic kidney disease (CKD) has been associated with a higher risk of cardiovascular disease (CVD). CKD patients present a decrease in the levels of the protein Klotho that accompanies the decrease in kidney function. This protein has been related to protective effects against CVD. However...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Javier Donate-Correa, Carla M. Ferri, Ernesto Martín-Núñez, Nayra Pérez-Delgado, Ainhoa González-Luis, Carmen Mora-Fernández, Juan F. Navarro-González
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/a9ea4b5ddcc44e2f8897e955395cf614
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Hannah Kaiser, et al.
Publicado: (2021)

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso R, et al.
Publicado: (2019)

A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease
por: Xiong J, et al.
Publicado: (2021)

Evaluation of endothelial function and subclinical atherosclerosis in patients with HIV infection
por: F. Arnaiz de las Revillas, et al.
Publicado: (2021)

Clinical significance of subclinical atherosclerosis in retinal vein occlusion
por: Minhyung Lyu, et al.
Publicado: (2021)

Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia
por: &Uuml;nsal C, et al.
Publicado: (2013)

Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors
por: Castellon X, et al.
Publicado: (2013)

Evaluation of FGF-19 and β-klotho as biomarkers in patients with intrahepatic cholestasis of pregnancy
por: Ahter Tanay Tayyar, et al.
Publicado: (2018)

Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice.
por: Cristina Sastre, et al.
Publicado: (2013)

Biomarker discovery in subclinical mycobacterial infections of cattle.
por: Meetu Seth, et al.
Publicado: (2009)

FMD and CIMT: Surrogate markers of atherosclerosis in subclinical and overt hypothyroidism in sub Himalyan Region
por: Bandana Kumari, et al.
Publicado: (2021)

Klotho, stem cells, and aging
por: Bian A, et al.
Publicado: (2015)

Reduced insulin clearance is linked to subclinical atherosclerosis in individuals at risk for type 2 diabetes mellitus
por: Elko Randrianarisoa, et al.
Publicado: (2020)

Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
por: Iurciuc S, et al.
Publicado: (2017)

Sleep-apnea risk and subclinical atherosclerosis in early-middle-aged retired National Football League players
por: Luyster FS, et al.
Publicado: (2017)

Klotho deficiency intensifies hypoxia-induced expression of IFN-α/β through upregulation of RIG-I in kidneys.
por: Asako Urabe, et al.
Publicado: (2021)

Klotho deficiency intensifies hypoxia-induced expression of IFN-α/β through upregulation of RIG-I in kidneys
por: Asako Urabe, et al.
Publicado: (2021)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Reza Fadaei, et al.
Publicado: (2018)

Extrarenal expression of α-klotho, the kidney related longevity gene, in Heterocephalus glaber, the long living Naked Mole Rat
por: M. Morevati, et al.
Publicado: (2021)

Intake of food rich in saturated fat in relation to subclinical atherosclerosis and potential modulating effects from single genetic variants
por: Federica Laguzzi, et al.
Publicado: (2021)

Individual with subclinical atherosclerosis have impaired proliferation of blood outgrowth endothelial cells, which can be restored by statin therapy.
por: Javier Martin-Ramirez, et al.
Publicado: (2014)

The Serum Concentration of Anti-Aging Proteins, Sirtuin1 and αKlotho in Patients with End-Stage Kidney Disease on Maintenance Hemodialysis
por: Zbroch E, et al.
Publicado: (2020)

Decrease in CD14++CD16+ Monocytes in Low-Immunological-Risk Kidney Transplant Patients with Subclinical Borderline Inflammation
por: Abelardo Caballero, et al.
Publicado: (2021)

Klotho inhibits neuronal senescence in human brain organoids
por: Mohammed R. Shaker, et al.
Publicado: (2021)

Predicting the coronary atherosclerosis severity in cardiac patients
por: Yuri N. Fedulaev, et al.
Publicado: (2021)

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: José Alberto Navarro-García, et al.
Publicado: (2021)

Subclinical Atherosclerosis Progression in Obese Children with Relevant Cardiometabolic Risk Factors Can Be Assessed through Carotid Intima Media Thickness
por: Monica-Simina Mihuta, et al.
Publicado: (2021)

Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran.
por: Iraj Najafi, et al.
Publicado: (2010)

Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
por: Olga A. Koshelskaya, et al.
Publicado: (2021)

Low serum klotho concentration is associated with worse cognition, psychological components of frailty, dependence, and falls in nursing home residents
por: Begoña Sanz, et al.
Publicado: (2021)

Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis
por: Luo Y, et al.
Publicado: (2021)

The Identification of Candidate Biomarkers and Pathways in Atherosclerosis by Integrated Bioinformatics Analysis
por: Youwei Lu, et al.
Publicado: (2021)

Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases
por: Jieshan Lin, et al.
Publicado: (2021)

Myxedema Coma and Acute Hepatopathy in a Dog with Severe Atherosclerosis
por: Leah C. Giralico, et al.
Publicado: (2021)

Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
por: Anna Waśkiel-Burnat, et al.
Publicado: (2021)

Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis
por: Jacinto,Thais A., et al.
Publicado: (2018)

Effectiveness and cost-effectiveness of a lifestyle modification programme in the prevention and treatment of subclinical, mild and moderate depression in primary care: a randomised clinical trial protocol
por: Alejandra Aguilar-Latorre, et al.
Publicado: (2020)

Alpha-Klotho is a novel predictor of treatment responsiveness in patients with heart failure
por: Manabu Taneike, et al.
Publicado: (2021)

Loss of αklotho causes reduced motor ability and short lifespan in zebrafish
por: Yurie Ogura, et al.
Publicado: (2021)

BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia
por: Betul Aslan Turkmen, et al.
Publicado: (2021)